Study of Inhaled Glucocorticosteroid Administration in Asthma Patients

Once-daily inhaled glucocorticosteroids treatment can sufficiently control airway inflammation in asthma patients.

Completed

Looking for future studies?

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hamamatsu University School of Medicine

Hamamatsu, 431-3192, Japan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Receive ICS for one year or more, with no change in dose within the previous 8 weeks

Exclusion criteria

Two or more courses of oral corticosteroid in the previous 12 months
Admission to hospital due to asthma in the previous 6 months
Admission to the intensive care unit due to asthma at any time in the past
Current cigarette smoker.

Treatment and study plan

Budesonide,hydrofluoroalkane-beclomethasone dipropionate

Drug

receive twice-daily administration

Budesonide,hydrofluoroalkane-beclomethasone

Drug

once-daily administration at bedtime

Primary outcomes

once-daily administration of inhaled glucocorticosteroids can control airway inflammation

Time frame: two-year

Sponsors and collaborators

Lead sponsor

Hamamatsu University

Other

Registry information

Official study title

Phase 4 Study of Once-Daily Inhaled Glucocorticosteroid Administration in Asthma Patients

Important dates

Study start: 2005
Study completion: 2007
First posted: Nov 16, 2007
Registry last updated: Mar 16, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed